About Evvy
Evvy is a company based in New York (United States) founded in 2002 by Priyanka Jain. Evvy has raised $19 million across 2 funding rounds from investors including LabCorp, Left Lane Capital and General Catalyst. The company has 9 employees as of December 31, 2023. Evvy offers products and services including Vaginal Health Test, Anti-Itch Vulva Cream, Hyaluronic Acid Suppositories, and Pure Boric Acid Suppositories. Evvy operates in a competitive market with competitors including Viome, Flore, uBiome, Jona and Kean Health, among others.
- Headquarter New York, United States
- Employees 9 as on 31 Dec, 2023
- Founders Priyanka Jain
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$19 M (USD)
in 2 rounds
-
Latest Funding Round
$14 M (USD), Series A
Sep 27, 2023
-
Investors
LabCorp
& 10 more
-
Employee Count
9
as on Dec 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Evvy
Evvy offers a comprehensive portfolio of products and services, including Vaginal Health Test, Anti-Itch Vulva Cream, Hyaluronic Acid Suppositories, and Pure Boric Acid Suppositories.
At-home swab for analyzing vaginal microbiome and health outcomes.
Cream to soothe and relieve vulva irritation and discomfort.
Suppositories for maintaining vaginal moisture and health balance.
Suppositories to address imbalances in the vaginal microbiome.
People of Evvy
Unlock access to complete
Unlock access to complete
Funding Insights of Evvy
Evvy has successfully raised a total of $19M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $14 million completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $14.0M
-
First Round
First Round
(14 Jun 2021)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2023 | Amount | Series A - Evvy | Valuation | Left Lane | |
| Jun, 2021 | Amount | Seed - Evvy | Valuation | General Catalyst , BoxGroup |
|
Investors in Evvy
Evvy has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include LabCorp, Left Lane Capital and General Catalyst.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are directed toward high-growth consumer and internet technology companies.
|
Founded Year | Domain | Location | |
|
Investment and transformation services for entrepreneurs in technology and finance sectors.
|
Founded Year | Domain | Location | |
|
Investments are focused on reproductive healthcare startups by Rhia Ventures.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Evvy
Financial Statements - Evvy
Evvy Comparisons
Competitors of Evvy
Evvy operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viome, Flore, uBiome, Jona and Kean Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Machine learning-based bioinformatics solutions for health insights are provided.
|
|
| domain | founded_year | HQ Location |
Customized probiotics for gut health are provided via stool analysis.
|
|
| domain | founded_year | HQ Location |
Provides comprehensive sequence datasets for human microbiome research and analysis.
|
|
| domain | founded_year | HQ Location |
AI-powered microbiome profiling platform to improve digestive health
|
|
| domain | founded_year | HQ Location |
At-home kits for gut microbiome, gene, and vaginal health testing services.
|
Frequently Asked Questions about Evvy
Evvy was founded in 2002 and raised its 1st funding round 19 years after it was founded.
Evvy is headquartered in New York, United States. It is registered at New York, New York, United States.
Priyanka Jain is the current CEO of Evvy. They have also founded this company.
Evvy is a funded company, having raised a total of $19M across 2 funding rounds to date. The company's 1st funding round was a Seed of $5M, raised on Jun 14, 2021.
As of Dec 31, 2023, the latest employee count at Evvy is 9.
Evvy was founded in 2002 in New York, United States, within the health technology sector. An online platform is maintained to distribute at-home test kits focused on vaginal microbiome analysis. Services include sample collection kits and diagnostic reporting, with operations centered in the U.S. to support womens health monitoring. The company is led by co-founder and CEO Priyanka Jain.
Evvy's top competitors include Viome, Flore and HyperSpectral.
Evvy offers Vaginal Health Test, Anti-Itch Vulva Cream, Hyaluronic Acid Suppositories, and Pure Boric Acid Suppositories.
Evvy has 11 investors. Key investors include LabCorp, Left Lane Capital, General Catalyst, Rhia Ventures, and Ingeborg Investments.